Literature DB >> 21778303

Cooperative role of caveolin-1 and C-terminal Src kinase binding protein in C-terminal Src kinase-mediated negative regulation of c-Src.

Aaron T Place1, Zhenlong Chen, Farnaz R Bakhshi, Guoquan Liu, John P O'Bryan, Richard D Minshall.   

Abstract

In the present study, we assessed the cooperative roles of C-terminal Src kinase (Csk) binding protein (Cbp) and Caveolin-1 (Cav-1) in the mechanism of Src family tyrosine kinase (SFK) inhibition by Csk. SFKs are inactivated by phosphorylation of their C-terminal tyrosine by Csk. Whereas SFKs are membrane-associated, Csk is a cytoplasmic protein and therefore requires membrane adaptors such as Cbp or Cav-1 for recruitment to the plasma membrane to mediate SFK inhibition. To determine the specific role of Cav-1 and Cbp in SFK inhibition, we measured c-Src activity in the absence of each membrane adaptor. It is noteworthy that in lungs and fibroblasts from Cav-1(-/-) mice, we observed increased expression of Cbp compared with wild-type (WT) controls. However, both c-Src activity and Csk localization at the membrane were similar between Cav-1(-/-) fibroblasts and WT cells. Likewise, Cbp depletion by small interfering RNA (siRNA) treatment of WT cells had no effect on basal c-Src activity, but it increased the phosphorylation state of Cav-1. Immunoprecipitation then confirmed increased association of Csk with phosphomimicking Cav-1. Knockdown of Cbp by siRNA in Cav-1(-/-) cells revealed increased basal c-Src activity, and re-expression of WT Cav-1 in the same cells reduced basal c-Src activity. Taken together, these results indicate that Cav-1 and Cbp cooperatively regulate c-Src activity by recruiting Csk to the membrane where it phosphorylates c-Src inhibitory tyrosine 529. Furthermore, when either Cav-1 or Cbp expression is reduced or absent, there is a compensatory increase in the phosphorylation state or expression level of the other membrane-associated Csk adaptor to maintain SFK inhibition.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21778303      PMCID: PMC3187524          DOI: 10.1124/mol.111.073957

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  29 in total

1.  Csk defines the ability of integrin-mediated cell adhesion and migration in human colon cancer cells: implication for a potential role in cancer metastasis.

Authors:  William Rengifo-Cam; Akio Konishi; Naoki Morishita; Hidetada Matsuoka; Takao Yamori; Shigeyuki Nada; Masato Okada
Journal:  Oncogene       Date:  2004-01-08       Impact factor: 9.867

2.  CSK: a protein-tyrosine kinase involved in regulation of src family kinases.

Authors:  M Okada; S Nada; Y Yamanashi; T Yamamoto; H Nakagawa
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

3.  Structure of the carboxyl-terminal Src kinase, Csk.

Authors:  Akira Ogawa; Yoshiharu Takayama; Hiroaki Sakai; Khoon Tee Chong; Satoru Takeuchi; Atsushi Nakagawa; Shigeyuki Nada; Masato Okada; Tomitake Tsukihara
Journal:  J Biol Chem       Date:  2002-03-07       Impact factor: 5.157

4.  Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette.

Authors:  H Lee; D Volonte; F Galbiati; P Iyengar; D M Lublin; D B Bregman; M T Wilson; R Campos-Gonzalez; B Bouzahzah; R G Pestell; P E Scherer; M P Lisanti
Journal:  Mol Endocrinol       Date:  2000-11

Review 5.  The hunting of the Src.

Authors:  G S Martin
Journal:  Nat Rev Mol Cell Biol       Date:  2001-06       Impact factor: 94.444

6.  Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src.

Authors:  S Nada; M Okada; A MacAuley; J A Cooper; H Nakagawa
Journal:  Nature       Date:  1991-05-02       Impact factor: 49.962

7.  Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice.

Authors:  A Imamoto; P Soriano
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

Review 8.  The Src and Csk families of tyrosine protein kinases in hemopoietic cells.

Authors:  L M Chow; A Veillette
Journal:  Semin Immunol       Date:  1995-08       Impact factor: 11.130

9.  Csk suppression of Src involves movement of Csk to sites of Src activity.

Authors:  B W Howell; J A Cooper
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

10.  Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo.

Authors:  S Li; R Seitz; M P Lisanti
Journal:  J Biol Chem       Date:  1996-02-16       Impact factor: 5.157

View more
  21 in total

1.  Structure-based reassessment of the caveolin signaling model: do caveolae regulate signaling through caveolin-protein interactions?

Authors:  Brett M Collins; Melissa J Davis; John F Hancock; Robert G Parton
Journal:  Dev Cell       Date:  2012-07-17       Impact factor: 12.270

2.  ICAM-1-activated Src and eNOS signaling increase endothelial cell surface PECAM-1 adhesivity and neutrophil transmigration.

Authors:  Guoquan Liu; Aaron T Place; Zhenlong Chen; Viktor M Brovkovych; Stephen M Vogel; William A Muller; Randal A Skidgel; Asrar B Malik; Richard D Minshall
Journal:  Blood       Date:  2012-07-17       Impact factor: 22.113

3.  Clinically relevant concentrations of lidocaine and ropivacaine inhibit TNFα-induced invasion of lung adenocarcinoma cells in vitro by blocking the activation of Akt and focal adhesion kinase.

Authors:  T Piegeler; M Schläpfer; R O Dull; D E Schwartz; A Borgeat; R D Minshall; B Beck-Schimmer
Journal:  Br J Anaesth       Date:  2015-11       Impact factor: 9.166

4.  Overexpression of Csk-binding protein decreases growth, invasion, and migration of esophageal carcinoma cells by controlling Src activation.

Authors:  Dong Zhou; Peng Dong; Yu-Min Li; Fa-Cai Guo; An-Ping Zhang; Run-Ze Song; Ya-Min Zhang; Zhi-Yong Li; Dong Yuan; Chuan Yang
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

5.  Src Family Kinases in Brain Edema After Acute Brain Injury.

Authors:  DaZhi Liu; Xiong Zhang; BeiLei Hu; Bradley P Ander
Journal:  Acta Neurochir Suppl       Date:  2016

6.  Endothelial barrier protection by local anesthetics: ropivacaine and lidocaine block tumor necrosis factor-α-induced endothelial cell Src activation.

Authors:  Tobias Piegeler; E Gina Votta-Velis; Farnaz R Bakhshi; Mao Mao; Graeme Carnegie; Marcelo G Bonini; David E Schwartz; Alain Borgeat; Beatrice Beck-Schimmer; Richard D Minshall
Journal:  Anesthesiology       Date:  2014-06       Impact factor: 7.892

Review 7.  Caveolae as plasma membrane sensors, protectors and organizers.

Authors:  Robert G Parton; Miguel A del Pozo
Journal:  Nat Rev Mol Cell Biol       Date:  2013-02       Impact factor: 94.444

8.  Inhibition of SRC family kinases protects hippocampal neurons and improves cognitive function after traumatic brain injury.

Authors:  Da Zhi Liu; Frank R Sharp; Ken C Van; Bradley P Ander; Rahil Ghiasvand; Xinhua Zhan; Boryana Stamova; Glen C Jickling; Bruce G Lyeth
Journal:  J Neurotrauma       Date:  2014-04-17       Impact factor: 5.269

9.  Nitrosation-dependent caveolin 1 phosphorylation, ubiquitination, and degradation and its association with idiopathic pulmonary arterial hypertension.

Authors:  Farnaz R Bakhshi; Mao Mao; Ayesha N Shajahan; Tobias Piegeler; Zhenlong Chen; Olga Chernaya; Tiffany Sharma; W Mark Elliott; Robert Szulcek; Harm Jan Bogaard; Suzy Comhair; Serpil Erzurum; Geerten P van Nieuw Amerongen; Marcelo G Bonini; Richard D Minshall
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

10.  Caveolin-1 modulates cardiac gap junction homeostasis and arrhythmogenecity by regulating cSrc tyrosine kinase.

Authors:  Kai-Chien Yang; Cody A Rutledge; Mao Mao; Farnaz R Bakhshi; An Xie; Hong Liu; Marcelo G Bonini; Hemal H Patel; Richard D Minshall; Samuel C Dudley
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.